CHICAGO, Oct. 9, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, LLY, MZOR, …
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Schlumberger (SLB) and PayPal (PYPL). …
Johnson & Johnson has again recalled thousands of its hip implants ... FactSet said that was an all-time high for the stock.
The Dow gained over the week following continuing optimism over Trump’s first actions as President and encouraging earnings results. Trump’s executive orders cleared the way for the completion of the Dakota Access and Keystone XL …
Pharmacyclics Inc., the cancer-drug maker that announced a deal with Johnson & Johnson on Thursday, fell the most in 19 months after RBC Capital Markets said the transaction means it is unlikely to be acquired. Pharmacyclics said …
Q. I own 100 shares of Johnson & Johnson and really like this investment. I would like to buy more shares. I'd hold on to them for a while. What do you think? Should I be liking this stock as much as I do? A. What's not to like? Buy shares …
But the business news on TV, in magazine articles and in newspaper stories is telling us that stocks are too high and that the stock market is going to ... Many of your stocks — including Johnson & Johnson, AT&T, NextEra Energy, Royal …
NewsOK6mon
US stock futures are higher this morning ... The US Food and Drug Administration approved a Johnson & Johnson (NYSE: JNJ) tuberculosis drug Sirturo. Middleby (NASDAQ: MIDD) bought Viking Range for $380 million in cash. The …
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 12 major stocks, including Goldman Sachs Group Inc (GS), PepsiCo, Inc. (PEP) and Johnson &
Yahoo!3mon
Recalls, lawsuits, investigations -- Johnson & Johnson has had them in droves ... But markets have shrugged. J&J's stock is up 32% in the past year. And as some Motrin and Tylenol products returned to shelves last year, sales soared.